Stockhead TV
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Cleo Diagnostics.
RELATED STOCKHEAD STORIES
Mining
JMM dines on diverse opportunity at Sydneyside luncheon
Health & Biotech
Health Check: Farewell, adieu as Argent Biopharma holders back ASX delisting
Experts
MoneyTalks: Tim Neesham has four ASX picks ready to get the rub of the green
Health & Biotech
ASX Health June Winners: Actinogen and Optiscan led a sector in good shape
Health & Biotech
ASX Health Stocks: Cleo gains FDA momentum for its ovarian cancer detection tech
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX takes a 1pc hit as inflation spooks; IMF bullish on China
News
ASX Small Caps Lunch Wrap: Who’s blasting a leaky Boeing rocket into space next week?
Health & Biotech
ASX Health Stocks: Cleo up 30pc and GTG up 13pc after cancer test kit progress
News
Top 10 at 10: REE-nergised rare earths explorers, biotech standouts lead Wednesday’s winners
Health & Biotech
ASX Health Stocks: CSL’s Phase 3 AEGIS-II trial disappoints, fails to meet primary efficacy endpoint
News
Rise and Shine: Everything you need to know before the ASX opens
News
ASX Small Caps Lunch Wrap: Who made American politics even dumber than usual this week?
News
In Case You Missed It: Some of the highest-grade lithium samples ever recorded in Pilbara
Health & Biotech
ASX Health Stocks: PYC on the same page with FDA, Cleo’s cancer test peer-reviewed
News
Closing Bell: ASX has best week ever… or at least since everything crashed last month. So… wait… damn you Friday!
Health & Biotech
